PTC THERAPEUTICS, INC. : LEERINK PARTNERS ASSUMES COVERAGE WITH OUTPERFORM VS MARKET PERFORM RATING; TARGET PRICE $98 VS $70

Reuters · 4d ago

Please log in to view news